|
Dr. G. P. S. Raghava
Bioinformatic Centre
IMTECH, INDIA
|
| | 
The prime/boost vaccine strategy has suggested that only immunodominant epitopes, rather than a large collection of defined epitopes with varying immunogenicity should be selected for vaccines.
If you are using this server please cite:
|
|
